Last edition
News about "Marksans Pharma"
Marksans Pharma completes acquisition of manufacturing site from Tevapharm India
Expand existing manufacturing capacity in India
Marksans Pharma | 20/04/2023 | By Sudeep Soparkar | 422
Marksans Pharma announces UK MHRA approval for Fluoxetine 20mg/5ml oral solution
The product will be manufactured at the plant of Bell, Sons & Co, UK
Marksans Pharma | 24/01/2023 | By Sudeep Soparkar | 415
Marksans acquires capacity from Tevapharm India, plans to double its manufacturing footprint
The transaction is in cash consideration and is expected to be finalised by April 1, 2023, subject to the usual closing conditions
Marksans Pharma | 12/10/2022 | By Sudeep Soparkar | 509
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy